Related Experiment Video
Updated: Mar 21, 2026

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel
Published on: September 8, 2017
Brain Tumor Genetic Modification Yields Increased Resistance to Paclitaxel in Physical Confinement
Loan Bui1, Alissa Hendricks1, Jamie Wright1
1Department of Bioengineering, University of Texas at Arlington, TX, USA.
Abstract:
Brain tumor cells remain highly resistant to radiation and chemotherapy, particularly malignant and secondary cancers. In this study, we utilized microchannel devices to examine the effect of a confined environment on the viability and drug resistance of the following brain cancer cell lines: primary cancers (glioblastoma multiforme and neuroblastoma), human brain cancer cell lines (D54 and D54-EGFRvIII), and genetically modified mouse astrocytes (wild type, p53-/-, p53-/- PTEN-/-, p53-/- Braf, and p53-/- PTEN-/- Braf). We found that loss of PTEN combined with Braf activation resulted in higher viability in narrow microchannels. In addition, Braf conferred increased resistance to the microtubule-stabilizing drug Taxol in narrow confinement. Similarly, survival of D54-EGFRvIII cells was unaffected following treatment with Taxol, whereas the viability of D54 cells was reduced by 75% under these conditions. Taken together, our data suggests key targets for anticancer drugs based on cellular genotypes and their specific survival phenotypes during confined migration.
Insights
Confined environments impact brain tumor cell survival and drug resistance. Specific genetic changes, like PTEN loss and Braf activation, increase viability and Taxol resistance in narrow microchannels.
Area of Science:
- Oncology
- Biophysics
- Cell Biology
Background:
- Brain tumor cells exhibit significant resistance to conventional therapies.
- Understanding cellular responses in microenvironments is crucial for developing new treatments.
Purpose of the Study:
- To investigate the influence of microchannel confinement on brain cancer cell viability and drug resistance.
- To identify genotype-specific drug targets and survival phenotypes.
Main Methods:
- Utilized microchannel devices to culture and analyze various brain cancer cell lines and genetically modified mouse astrocytes.
- Assessed cell viability and drug resistance (Taxol) under confined conditions.
Main Results:
- Loss of PTEN combined with Braf activation enhanced cell viability in narrow microchannels.
- Braf activation increased resistance to Taxol in confined environments.
- D54-EGFRvIII cells showed Taxol resistance, unlike D54 cells which had 75% reduced viability.
Conclusions:
- Cellular genotype and specific survival phenotypes in confined migration are key determinants for anticancer drug targeting.
- Microchannel confinement influences drug resistance, suggesting novel therapeutic strategies.
Related Concept Videos
Treatment Resistant Cancers
Drugs that Stabilize Microtubules
Targeted Cancer Therapies
There are several types of targeted therapies against...
Abnormal Proliferation
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

